Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma

Clinical Infectious Diseases

Volumn 23, Issue 1, 1996, Pages 179-181

  Campbell, Wayne N ^a   Hendrix, Elizabeth ^b   Cryz Jr , Stanley ^b   Cross, Alan S ^b  

^a R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KLEBSIELLA VACCINE; KLEBVAX; NOSOVAC; PSEUDOMONAS VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY RESPONSE; BLUNT TRAUMA; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG SAFETY; FEMALE; FEVER; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOGENICITY; INJECTION PAIN; INJURY SCALE; INTRAMUSCULAR DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; NOTE; PENETRATING TRAUMA; PRIORITY JOURNAL; PSEUDOMONAS;

EID: 0029812756     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.1.179     Document Type: Note

References (4)

1. Stillwell M, Caplan ES. The septic multiple-trauma patient. Infect Dis Clin North Am 1989;3:155-83.
2. Cross AS, Sadoff JC, Cryz SJ. Vaccines against Klebsiella and Pseudomonas infections. In: Woodrow GC, Levine MM, eds. New generation vaccines. 1st ed. New York: Marcel Dekker, 1990:699-713.
3. Greenspan L, McLellan BA, Greig H. Abbreviated injury scale and injury severity score: a scoring chart. J Trauma 1985;25:60-4.
4. Edelman R, Taylor DN, Wasserman SS, et al. Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously. Vaccine 1994;12:1288-94.